Literature DB >> 19153359

Exacerbation of undiagnosed mycosis fungoides during treatment with etanercept.

Philippe Lafaille, Danielle Bouffard, Nathalie Provost.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19153359     DOI: 10.1001/archdermatol.2008.526

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN: 0003-987X


× No keyword cloud information.
  9 in total

Review 1.  Is there truly a risk of lymphoma from biologic therapies?

Authors:  Erica Dommasch; Joel M Gelfand
Journal:  Dermatol Ther       Date:  2009 Sep-Oct       Impact factor: 2.851

2.  Predictors of response to extracorporeal photopheresis in advanced mycosis fungoides and Sézary syndrome.

Authors:  Laura Y McGirt; Christopher Thoburn; Allan Hess; Eric C Vonderheid
Journal:  Photodermatol Photoimmunol Photomed       Date:  2010-08       Impact factor: 3.135

3.  [CD30-positive anaplastic large cell T-cell lymphoma developing during immunosuppressive therapy of pityriasis rubra pilaris with ustekinumab].

Authors:  D Humme; M Beyer; H-J Röwert-Huber; W Sterry; S Philipp
Journal:  Hautarzt       Date:  2013-03       Impact factor: 0.751

4.  Progression of undiagnosed cutaneous lymphoma after anti-tumor necrosis factor-alpha therapy.

Authors:  Maria Estela Martinez-Escala; Alba L Posligua; Heather Wickless; Audrey Rutherford; Kimberly A Sable; Belen Rubio-Gonzalez; Xiaolong A Zhou; Jason B Kaplan; Barbara Pro; Jaehyuk Choi; Christiane Querfeld; Steven T Rosen; Joan Guitart
Journal:  J Am Acad Dermatol       Date:  2018-01-04       Impact factor: 11.527

5.  Sources of information on lymphoma associated with anti-tumour necrosis factor agents: comparison of published case reports and cases reported to the French pharmacovigilance system.

Authors:  Hélène Théophile; Thierry Schaeverbeke; Ghada Miremont-Salamé; Abdelilah Abouelfath; Valentine Kahn; Françoise Haramburu; Bernard Bégaud
Journal:  Drug Saf       Date:  2011-07-01       Impact factor: 5.606

Review 6.  TNF-α blocker therapy and solid malignancy risk in ANCA-associated vasculitis.

Authors:  Francisco Silva; Marcela Cisternas; Ulrich Specks
Journal:  Curr Rheumatol Rep       Date:  2012-12       Impact factor: 4.592

7.  A case for histologic verification of the diagnosis of atypical psoriasis before systemic therapy.

Authors:  Ruth Rohl; Daniel Bax; Shirley Schierer; Paul N Bogner; Francisco Hernandez-Ilizaliturri; Gyorgy Paragh
Journal:  JAAD Case Rep       Date:  2018-04-30

Review 8.  Safety and danger of biologic treatments in psoriasis in context of cutaneous T-cell lymphoma (CTCL).

Authors:  Karol Kołkowski; Małgorzata Sokołowska-Wojdyło
Journal:  Postepy Dermatol Alergol       Date:  2021-10-25       Impact factor: 1.837

9.  A Case of Cutaneous T-cell Lymphoma, Masquerading as Psoriasis, Was Given Etanercept and Secukinumab: Emphasizing the Need for Biopsy Confirmation before Starting Biologics.

Authors:  Abhishek De; Tanumay Raychaudhury; Murlidhar Rajagopalan; Aarti Sarda; Nidhi Sharma
Journal:  Indian J Dermatol       Date:  2017 Sep-Oct       Impact factor: 1.494

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.